NPI: 1255307039 · NORWICH, CT 06360 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/23/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/23/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 26,388 | $434K |
| 2019 | 26,647 | $265K |
| 2020 | 22,980 | $194K |
| 2021 | 16,765 | $212K |
| 2022 | 8,309 | $81K |
| 2023 | 7,214 | $51K |
| 2024 | 2,807 | $14K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 36,620 | 2,780 | $309K |
| 83970 | 2,219 | 1,834 | $287K | |
| 82728 | 2,223 | 1,879 | $242K | |
| 83550 | 1,771 | 1,514 | $132K | |
| 83540 | 2,212 | 1,846 | $107K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,934 | 1,761 | $58K |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,799 | 1,267 | $30K |
| 82108 | 116 | 112 | $24K | |
| A4657 | Syringe, with or without needle, each | 2,555 | 2,182 | $14K |
| 85041 | 2,338 | 1,955 | $13K | |
| 85045 | 2,043 | 1,707 | $11K | |
| 85048 | 2,338 | 1,955 | $8K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 570 | 451 | $7K |
| J1756 | Injection, iron sucrose, 1 mg | 4,772 | 1,259 | $5K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 485 | 215 | $4K |
| G0008 | Administration of influenza virus vaccine | 75 | 71 | $148.65 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 356 | 80 | $0.00 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 385 | 206 | $0.00 |
| 90662 | 13 | 12 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 174 | 24 | $0.00 |
| 90670 | 18 | 15 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 18 | 15 | $0.00 |
| 90674 | 60 | 57 | $0.00 | |
| 82746 | 16 | 13 | $0.00 |